Calcium handling:a strategy to fight neurodegeneration in Alzheimer's disease

被引：0
|
作者：
Livia La Barbera [1 ,2 ]
Elena Spoleti [1 ]
Marcello D'Amelio [2 ,3 ]
机构：
[1] Department of Sciences and Technologies for Humans and Environment,Università Campus Bio-Medico di Roma
[2] Department of Experimental Neurosciences,IRCCS Santa Lucia Foundation  3. Department of Medicine and Surgery,Università Campus Bio-Medico di Roma
来源：
Neural Regeneration Research | 2023年 / 12期
关键词：
D O I：
暂无
中图分类号：
R749.16 [];
学科分类号：
100203 ;
摘要：
In the last few years,preclinical and clinical studies identified the ventral tegmental area(VTA) as one of the first brain regions to be affected in the prodromal phase of Alzheimer’s disease(AD).The VTA is a deep midbrain nucleus rich in dopaminergic neurons that innervates and releases dopamine(DA) in several cortical and subcortical brain regions.DA plays a crucial role in the modulation of both cognitive and noncognitive functions and failure of its release underlies both cognitive and neuropsychiatric symptoms in patients with AD.
引用
收藏
页码：2685 / 2686
页数：2
相关论文
共 50 条
  • [1] Calcium handling: a strategy to fight neurodegeneration in Alzheimer's disease
    La Barbera, Livia
    Spoleti, Elena
    D'Amelio, Marcello
    NEURAL REGENERATION RESEARCH, 2023, 18 (12) : 2685 - 2686
  • [2] Hypoxic preconditioning: A strategy to fight Alzheimer's disease?
    Moreira, Paula
    Correia, Sonia
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 51 - 51
  • [3] Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond
    Webber, Elise K.
    Fivaz, Marc
    Stutzmann, Grace E.
    Griffioen, Gerard
    ALZHEIMERS & DEMENTIA, 2023, 19 (08) : 3701 - 3717
  • [4] Dysfunctional intracellular calcium homoeostasis: a central cause of neurodegeneration in Alzheimer's disease
    O'Neill, C
    Cowburn, RF
    Bonkale, WL
    Ohm, TG
    Fastbom, J
    Carmody, M
    Kelliher, M
    NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE, 2001, 67 : 177 - 194
  • [5] Kynurenines, neurodegeneration and Alzheimer's disease
    Kincses, Zsigmond Tamas
    Toldi, Jozsef
    Vecsei, Laszlo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (08) : 2045 - 2054
  • [6] APOE in Alzheimer's disease and neurodegeneration
    Butterfield, D. Allan
    Johnson, Lance A.
    NEUROBIOLOGY OF DISEASE, 2020, 139
  • [7] ProNGF and Neurodegeneration in Alzheimer's Disease
    Fahnestock, Margaret
    Shekari, Arman
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [8] Alzheimer's Disease and Retinal Neurodegeneration
    Guo, L.
    Duggan, J.
    Cordeiro, M. F.
    CURRENT ALZHEIMER RESEARCH, 2010, 7 (01) : 3 - 14
  • [9] Tau, Neurodegeneration and Alzheimer's Disease
    Alonso, Alejandra del Carmen
    CURRENT ALZHEIMER RESEARCH, 2010, 7 (08) : 653 - 655
  • [10] Alzheimer's disease neurodegeneration markers in Alzheimer's disease neuroimaging initiative
    Andriuta, D.
    Moullart, V.
    Schraen, S.
    Meyer, M. -E.
    Godefroy, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 93 - 93
12345